Ignacio Braña
YOU?
Author Swipe
View article: Cardiometabolic Candidate Endotypes in Psoriatic Disease: Integration of Clinical, Metabolic, and Immunogenetic Data Across Psoriasis and Psoriatic Arthritis
Cardiometabolic Candidate Endotypes in Psoriatic Disease: Integration of Clinical, Metabolic, and Immunogenetic Data Across Psoriasis and Psoriatic Arthritis Open
Background/objectives: Psoriatic disease (PsD) encompasses psoriasis (PsO) and psori-atic arthritis (PsA) and is associated with heterogeneous cardiometabolic risk. Inte-grating immunogenetic markers such as HLA-Cw6 into data-driven analys…
View article: Drs. Queiro and Braña reply
Drs. Queiro and Braña reply Open
View article: Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles
Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles Open
Background: Personalized medicine in axial spondyloarthritis (axSpA) requires accurate tools to assess inflammation and tailor disease monitoring. The role of traditional biomarkers such as erythrocyte sedimentation rate (ESR) and C-reacti…
View article: Dose Tapering of Advanced Therapies in Psoriatic Arthritis: Clinical Predictors and Outcomes in a Biosimilar-Dominant Real-Life Cohort
Dose Tapering of Advanced Therapies in Psoriatic Arthritis: Clinical Predictors and Outcomes in a Biosimilar-Dominant Real-Life Cohort Open
Background: Dose tapering in patients with psoriatic arthritis (PsA) who achieve sustained treatment targets is a common but underexplored strategy, particularly in those receiving TNFα inhibitor biosimilars (TNFibs). This study aimed to a…
View article: POS0494 CLINICAL PRESENTATION OF IGG4-RELATED DISEASE. MULTICENTER STUDY AND LITERATURE REVIEW
POS0494 CLINICAL PRESENTATION OF IGG4-RELATED DISEASE. MULTICENTER STUDY AND LITERATURE REVIEW Open
View article: ABS0300 FREQUENCY AND FACTORS ASSOCIATED WITH STRUCTURAL DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS
ABS0300 FREQUENCY AND FACTORS ASSOCIATED WITH STRUCTURAL DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS Open
View article: ABS0275 EFFECTIVENESS OF THE ANTIFIBROTIC NINTEDANIB COMBINED WITH DMARDS IN JOINT AND PULMONAR DOMAINS OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 74 PATIENTS
ABS0275 EFFECTIVENESS OF THE ANTIFIBROTIC NINTEDANIB COMBINED WITH DMARDS IN JOINT AND PULMONAR DOMAINS OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 74 PATIENTS Open
View article: ABS0232 A COMPARISON BETWEEN EARLY AND ESTABLISHED AXIAL SPONDYLOARTHRITIS BASED ON THE NEW ASAS DEFINITION OF EARLY DISEASE
ABS0232 A COMPARISON BETWEEN EARLY AND ESTABLISHED AXIAL SPONDYLOARTHRITIS BASED ON THE NEW ASAS DEFINITION OF EARLY DISEASE Open
View article: ABS0358 THE PHENOTYPE OF PSORIATIC ARTHRITIS MAY CHANGE SUBSTANTIALLY DEPENDING ON WHICH DISEASE DOMAIN OCCURS FIRST OR WHETHER BOTH OCCUR SIMULTANEOUSLY
ABS0358 THE PHENOTYPE OF PSORIATIC ARTHRITIS MAY CHANGE SUBSTANTIALLY DEPENDING ON WHICH DISEASE DOMAIN OCCURS FIRST OR WHETHER BOTH OCCUR SIMULTANEOUSLY Open
View article: ABS0301 PsAID AND ASAS-HI THRESHOLDS TO IDENTIFY THE DIFFERENT DAPSA CATEGORIES IN PATIENTS WITH PSORIATIC ARTHRITIS
ABS0301 PsAID AND ASAS-HI THRESHOLDS TO IDENTIFY THE DIFFERENT DAPSA CATEGORIES IN PATIENTS WITH PSORIATIC ARTHRITIS Open
View article: ABS1028 PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: INSIGHTS FROM A MULTICENTER SPANISH STUDY ON THE IMPACT OF ANTIPHOSPHOLIPID ANTIBODIES AND APS
ABS1028 PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: INSIGHTS FROM A MULTICENTER SPANISH STUDY ON THE IMPACT OF ANTIPHOSPHOLIPID ANTIBODIES AND APS Open
View article: The VITACORA- 19 and PsAID questionnaires are equally valid for assessing the impact of psoriatic arthritis on patients' quality of life
The VITACORA- 19 and PsAID questionnaires are equally valid for assessing the impact of psoriatic arthritis on patients' quality of life Open
Background and aims Health-related quality of life (HRQoL) is an often-underestimated aspect in psoriatic arthritis (PsA). We aimed to compare the VITACORA-19 and PsAID (Psoriatic Arthritis Impact of Disease) questionnaires to assess QoL i…
View article: Real-World Evidence of the Antifibrotic Nintedanib in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 74 Patients
Real-World Evidence of the Antifibrotic Nintedanib in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 74 Patients Open
View article: Prevalence and Structural Damage-Associated Factors in Psoriatic Arthritis: A Real-Life Study in the Era of Advanced Therapies
Prevalence and Structural Damage-Associated Factors in Psoriatic Arthritis: A Real-Life Study in the Era of Advanced Therapies Open
View article: Do the Activity Indices Used in Axial Spondyloarthritis Capture the Relationships Between Obesity, Smoking and Disease Activity in the Same Way?
Do the Activity Indices Used in Axial Spondyloarthritis Capture the Relationships Between Obesity, Smoking and Disease Activity in the Same Way? Open
Background/Objectives: Obesity and smoking have been related to increased disease activity in axial spondyloarthritis (axSpA), but these associations might vary depending on the composite index chosen to assess disease activity. We aimed t…
View article: Analysis of Disease Activity in Axial Spondyloarthritis Reveals That the Obesity-Activity Association Could Vary Depending on the Activity Index Chosen for This Purpose
Analysis of Disease Activity in Axial Spondyloarthritis Reveals That the Obesity-Activity Association Could Vary Depending on the Activity Index Chosen for This Purpose Open
Background and aims: Obesity has been related to increased disease activity in axial spondyloarthritis (axSpA), but this association might vary depending on the composite index chosen to assess disease activity. We aim to check that possib…
View article: Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease
Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease Open
Background/Objectives: In recent years, a possible connection between HLA-Cw6 and a distinctive cardiometabolic (CM) profile in patients with psoriatic disease (PsD) has been proposed, although there is still little support for this. Our a…
View article: Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease
Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease Open
Background and aims: In recent years, a possible connection between HLA-Cw6 and a distinctive cardiometabolic (CM) profile in patients with psoriatic disease (PsD) has been proposed, although there is still little support for this. Our aim…
View article: Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease
Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease Open
Background: Cardiovascular comorbidity is a common companion of psoriasis and psoriatic arthritis (PsA). Recently, a significant link has been found between the HLA-Cw6 allele and a better cardiometabolic profile in these patients. We aime…
View article: HLA-C*06–defined endotype in psoriatic disease: an ever-widening landscape
HLA-C*06–defined endotype in psoriatic disease: an ever-widening landscape Open
View article: Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?
Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients? Open
View article: AB1109 TREATMENT RETENTION AND SAFETY OF IXEKIZUMAB IN A POPULATION WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC AND TARGETED SYNTHETIC DMARDS
AB1109 TREATMENT RETENTION AND SAFETY OF IXEKIZUMAB IN A POPULATION WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC AND TARGETED SYNTHETIC DMARDS Open
View article: POS0028 COMPARATIVE STUDY BETWEEN THE VITACORA AND PSAID QUESTIONNAIRES IN ESTIMATING QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS
POS0028 COMPARATIVE STUDY BETWEEN THE VITACORA AND PSAID QUESTIONNAIRES IN ESTIMATING QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS Open
View article: POS0673 ARE PATIENTS WITH AXIAL SPONDYLOARTHRITIS WHO WERE BREASTFED LESS PRONE TO MORE ACTIVE AND SEVERE DISEASE?
POS0673 ARE PATIENTS WITH AXIAL SPONDYLOARTHRITIS WHO WERE BREASTFED LESS PRONE TO MORE ACTIVE AND SEVERE DISEASE? Open
Background Breast milk is the first source of microorganisms that colonize the gastrointestinal tract and a key factor in shaping the intestinal microbiome. It is currently believed that alterations in the intestinal microbiota are key in …
View article: Osteomalacia in Adults: A Practical Insight for Clinicians
Osteomalacia in Adults: A Practical Insight for Clinicians Open
The term osteomalacia (OM) refers to a series of processes characterized by altered mineralization of the skeleton, which can be caused by various disorders of mineral metabolism. OM can be genetically determined or occur due to acquired d…
View article: Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?
Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease? Open
Background and aims: Breastfeeding is recognized as one of the most influential drivers of the gut microbiome. In turn, alterations in the gut microbiome may play a role in the development and severity of spondyloarthritis (SpA). We aimed …
View article: Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes
Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes Open
Background and aims: The effect of smoking on disease activity and quality of life (QoL) in spondyloarthritis (SpA) is far from clear. We aimed to evaluate the relationship between smoking and these outcomes in patients with axial SpA (axS…
View article: Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience Open
Background and objectives: Information on the performance of ixekizumab (IXE) in patients with psoriatic arthritis (PsA) in clinical practice is scarce. We aimed to analyze the retention rate and safety of IXE in patients with PsA in routi…
View article: Active Disease in Psoriatic Arthritis: An Assessment of Spondyloarthritis International Society Health Index (ASAS-HI)–based Analysis
Active Disease in Psoriatic Arthritis: An Assessment of Spondyloarthritis International Society Health Index (ASAS-HI)–based Analysis Open
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis that affects one-third of patients with psoriasis (PsO). PsA is a relatively common condition in rheumatology clinics. In fact, the prevalence of PsA increased to approximately …
View article: Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA‐C∗06 Status
Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA‐C∗06 Status Open
The human leukocyte antigen‐C∗06 (HLA‐C∗06, formerly HLA‐Cw6) is the main genetic biomarker in psoriatic disease. It has been related to several phenotypic traits in psoriatic disease, but its role in relation to cardiometabolic comorbidit…